SCHEMBL1610366

SCHEMBL1610366

COC(=O)c1nc(C2CC2)nc(NC(CC2CCCCC2)C(=O)OC)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 6/20 0.39
CNR2 P34972 2/20 0.37
CHRM3 P20309 2/20 0.33
PDE4A P27815 2/20 0.33
PDE4B Q07343 2/20 0.33
PDE4C Q08493 2/20 0.33
PDE4D Q08499 2/20 0.33
CYP2C9 P11712 1/20 0.33
NPR3 P17342 1/20 0.33
CYP2C19 P33261 1/20 0.33
GRN P28799 1/20 0.33
SORT1 Q99523 1/20 0.33
CTSL P07711 1/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33
P2RX3 P56373 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1610367 1.00 PDE10A (0.39) PDE10ACNR2CHRM3PDE4APDE4B
SCHEMBL1610708 0.86 PDE10A (0.41) PDE10ACHRM3PDE4APDE4BPDE4C
SCHEMBL1609364 0.80 PDE10A (0.39) PDE10ACHRM3PDE4APDE4BPDE4C
SCHEMBL1610414 0.80 PDE10A (0.39) PDE10ACHRM3PDE4APDE4BPDE4C
SCHEMBL1609302 0.80 PDE10A (0.43) PDE10ACYP2C9CYP2C19
SCHEMBL1610877 0.80 NOS2 (0.38) PDE10APDE4BPDE4DP2RX3
SCHEMBL1610879 0.80 NOS2 (0.38) PDE10APDE4BPDE4DP2RX3
SCHEMBL1609224 0.79 PDE10A (0.43) PDE10ACHRM3PDE4APDE4BPDE4C
SCHEMBL12712978 0.79 P2RX3 (0.39) PDE10AP2RX3
SCHEMBL1609304 0.79 NPSR1 (0.42) CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086759-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086759-A1 CHEMICAL COMPOUNDS DDT, PNPO, CBR3 PDE10A 1704/4885CNR2 1000/4885CHRM3 2705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.